Japan Hyperglycemics Research
11 comprehensive market analysis studies and research reports on the Japan Hyperglycemics sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 75 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Middle East And Africa Insulin Market
CAGR: 3.78%
Study Period : 2019 - 2030
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
CAGR: 4.61%
Study Period : 2019 - 2030
North America Insulin Market
CAGR: 3.91%
Study Period : 2019 - 2030
North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market
CAGR: 8.67%
Study Period : 2019 - 2030
Europe Sodium-dependent Glucose Cotransporter 2 Market
CAGR: 9.10%
Study Period : 2019 - 2030
Healthcare
Categories
11 Healthcare Reports
Categories
Showing 11 of 11 results in Hyperglycemics
SGLT2 Market
CAGR: 8.68%
Study Period: 2019 - 2030
Country Covered: Japan
Major Players:Janssen, Boehringer Ingelheim, Eli Lilly and Company, Astellas Pharma, AstraZeneca
Basal Insulin Market
CAGR: 4.70%
Study Period: 2019 - 2030
Country Covered: Japan
Major Players:Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon, Wockhardt
Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market
CAGR: 8.35%
Study Period: 2019 - 2030
Country Covered: Japan
Major Players:Eli Lilly and Company, Boehringer Ingelheim, Janssen, AstraZeneca, Bristol-Myers Squibb
TRENDING REPORTS
Middle East And Africa Insulin Market
CAGR: 3.78%
Study Period : 2019 - 2030
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
CAGR: 4.61%
Study Period : 2019 - 2030
North America Insulin Market
CAGR: 3.91%
Study Period : 2019 - 2030
North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market
CAGR: 8.67%
Study Period : 2019 - 2030
Europe Sodium-dependent Glucose Cotransporter 2 Market
CAGR: 9.10%
Study Period : 2019 - 2030
Insulin Market
CAGR: 3.87%
Study Period: 2019 - 2030
Country Covered: Japan
Major Players:Novo Nordisk, Eli Lilly and Company, Pfizer, Sanofi, Biocon Biologics
APAC Meglitinide Market
CAGR: 1.7%
Study Period: 2019 - 2030
Country Covered: Japan
Major Players:Novo Nordisk, Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon
APAC Biguanide Market
CAGR: 2%
Study Period: 2019 - 2030
Country Covered: Japan
Major Players:Takeda Pharmaceuticals, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Merck, Sanofi
Insulin Glargine Market
CAGR: 6.28%
Study Period: 2019 - 2030
Country Covered: Japan
Major Players:Sanofi, Novo Nordisk, Biocon, Eli Lilly and Company, Julphar
Sulfonylureas Market
CAGR: 3.12%
Study Period: 2019 - 2030
Country Covered: Japan
Major Players:Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories
Meglitinide Market
CAGR: 2.21%
Study Period: 2019 - 2030
Country Covered: Japan
Major Players:Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk
Biguanides Market
CAGR: 2.34%
Study Period: 2019 - 2030
Country Covered: Japan
Major Players:Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Sanofi, Merck
Asia - Pacific Human Insulin Market
CAGR: 2.54%
Study Period: 2019 - 2030
Country Covered: Japan
Major Players:Novo Nordisk, Eli Lilly and Company, Sanofi, Biocon, Gan & Lee
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
